New cancer drug targets tough tumors in early trial
Disease control
Ongoing
This early-stage study tests a new drug called GH2616 in people with advanced solid tumors that have not responded to other treatments. The drug works by blocking a protein that helps cancer cells divide, which may stop tumor growth. The main goals are to check safety, find the b…
Phase: PHASE1 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 10:52 UTC